Home › NDC Lookup › RxCUI directory › RxCUI 1303325

Undecylenic acid 250 MG/ML Topical Solution [Hongo Killer Treatment] — RxCUI 1303325

RxNorm drug concept · Semantic branded drug
RxCUI 1303325 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1303325
Official nameUndecylenic acid 250 MG/ML Topical Solution [Hongo Killer Treatment]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asHongo Killer Treatment 25 % Topical Solution; Hongo Killer Treatment 250 MG/ML Topical Solution
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Undecylenic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats three common fungal skin infections: athlete's foot (the itchy, scaly condition that affects the feet and toes), jock itch (a fungal rash in the groin area), and ringworm...
  • What exactly does undecylenic acid treat?
  • For athlete's foot and ringworm, most products are used daily for 4 full weeks. For jock itch, 2 weeks of daily use is typically recommended. Some nail products note that visible i...
  • That depends on the product. Most undecylenic acid creams, sprays, and general topical solutions are not effective on nails and should not be used there. However, some products — l...
📖 Read our full Undecylenic guide →

🕸️ Concept Web — How Undecylenic acid 250 MG/ML Topical Solution [Hon... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Undecylenic acid 250 MG/ML Topical Solution [Hongo Killer Treatment] RxCUI 1303325

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Undecylenate 314881
    • Undecylenic acid 10989
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Hongo Killer Treatment 1101788
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Undecylenate Topical Solution 657495
    • Undecylenic acid Topical Solution 2646976
    • Undecylenate Topical Product 1159957
    • Undecylenic acid Topical Product 2661425
    • Undecylenate Topical Solution [Hongo Killer Treatment] 1101792
    • Undecylenic acid Topical Solution [Hongo Killer Treatment] 2657097
    • Hongo Killer Treatment Topical Product 1171278
    • Topical Solution 316986
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Undecylenic acid 250 MG/ML Topical Solution SCD · 998329
  • Undecylenic acid 250 MG/ML SCDC · 998328
  • Undecylenate Topical Solution SCDF · 657495
  • Undecylenic acid Topical Solution SCDFP · 2646976
  • Undecylenate Topical Product SCDG · 1159957
  • Undecylenic acid Topical Product SCDGP · 2661425

Brand-Name Concepts

  • Undecylenic acid 250 MG/ML [Hongo Killer Treatment] SBDC · 1303324
  • Undecylenate Topical Solution [Hongo Killer Treatment] SBDF · 1101792
  • Undecylenic acid Topical Solution [Hongo Killer Treatment] SBDFP · 2657097
  • Hongo Killer Treatment Topical Product SBDG · 1171278
  • Hongo Killer Treatment BN · 1101788

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1303325 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
58593-0826-01 30 mL in 1 BOTTLE, WITH APPLICATOR (58593-826-01) Hongo Killer Efficient Laboratories Inc 2012-07-01
Observed labelers: Efficient Laboratories Inc (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.